|
311 |
Identifying Major Congenital Malformations in the UK General Practice Research Database (GPRD)
Enthalten in Drug safety Bd. 33, 21.11.2012, Nr. 9, date:9.2010: 741-750
|
|
|
|
312 |
Identifying Patients Likely to Have Atopic Dermatitis
Enthalten in American journal of clinical dermatology Bd. 11, 26.8.2012, Nr. 3, date:6.2010: 211-215
|
|
|
|
313 |
Idiopathic Breakthrough Pain
Enthalten in Clinical drug investigation Bd. 30, 17.9.2012, Nr. 2, date:7.2010: 27-29
|
|
|
|
314 |
Immunotherapy for Cervical Cancer
Enthalten in BioDrugs Bd. 24, 16.8.2012, Nr. 2, date:4.2010: 109-129
|
|
|
|
315 |
Impact of Intravenous Naltrexone on Intravenous Morphine-Induced High, Drug Liking, and Euphoric Effects in Experienced, Nondependent Male Opioid Users
Enthalten in Drugs in R & D Bd. 11, 25.11.2012, Nr. 3, date:9.2011: 259-275
|
|
|
|
316 |
Impact of Pregabalin Treatment on Pain, Pain-Related Sleep Interference and General Well-Being in Patients with Neuropathic Pain
Enthalten in Clinical drug investigation Bd. 31, 24.8.2012, Nr. 6, date:6.2011: 417-426
|
|
|
|
317 |
Impact of Psoriasis on Patients’ Work and Productivity
Enthalten in American journal of clinical dermatology Bd. 10, 13.9.2012, Nr. 6, date:12.2009: 407-410
|
|
|
|
318 |
Impact of Revisions to the F-Tag 309 Surveyors’ Interpretive Guidelines on Pain Management among Nursing Home Residents
Enthalten in Drugs & aging Bd. 29, 23.12.2012, Nr. 5, date:5.2012: 385-393
|
|
|
|
319 |
Impact of Safety-Related Regulatory Action on Clinical Practice
Enthalten in Drug safety Bd. 35, 13.12.2012, Nr. 5, date:5.2012: 373-385
|
|
|
|
320 |
Impact of Transformation of Negative Values and Regression Models on Differences Between the UK and US EQ-5D Time Trade-Off Value Sets
Enthalten in PharmacoEconomics Bd. 30, 23.12.2012, Nr. 12, date:12.2012: 1203-1214
|
|
Administration
